Nicholas Hollenkamp, MD
Otolaryngology · Columbus, INNPI 1891792149
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $8,705 of the $10,164 with a category attached, or 85.7%. It is spread thinly across 24 manufacturers, the largest accounting for just 21.4% — the pattern of someone who eats at a lot of different presentations.
Across 253 payments — averaging $40.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$2K
- Aerin Medical Inc.$2K
- Regeneron Healthcare Solutions, Inc.$2K
- Medtronic$2K
- Spirair, Inc.$750
- GSK$397
- plus $1K from 18 others
What the payments were for
- Travel & lodging$1,26412%
- Food & beverage$8,70586%
- Education$1952%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 53 | $2,176 |
| Aerin Medical Inc. | 29 | $2,031 |
| Regeneron Healthcare Solutions, Inc. | 75 | $1,773 |
| Medtronic(2 entities) | 32 | $1,720 |
| Spirair, Inc. | 2 | $750 |
| GSK | 20 | $397 |
| Medline Industries LP | 2 | $362 |
| Sanofi | 9 | $286 |
| Optinose US, Inc. | 12 | $206 |
| AstraZeneca | 1 | $125 |
| Acclarent, Inc | 3 | $65 |
| Amgen | 2 | $41 |
| Hologic Sales And Service, LLC | 2 | $35 |
| Davol Inc. | 1 | $25 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $24 |
| Vertex | 1 | $20 |
| Shire North American Group Inc | 1 | $19 |
| Merck | 1 | $18 |
| Inspire Medical Systems, Inc. | 1 | $17 |
| Phathom Pharmaceuticals, Inc. | 1 | $17 |
| Pfizer | 1 | $16 |
| Kaleo, Inc. | 1 | $14 |
| AbbVie | 1 | $14 |
| Arbor Pharmaceuticals, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Custom Packs by Sorin Biomedical$1,705
- SeptAlign$1,499
- NUVENT$1,093
- TURBALIGN$844
- VIVAER STYLUS$529
- RHINAER STYLUS$529
- Vivaer RF Stylus$468
- ENTELLUS - XPRESS ENT DILATION SYSTEM$415
- XPRESS ENT DILATION SYSTEM$277
- ENTELLUS - FIAGON SINUS NAVIGATION SYSTEM$172
- CMI$168
- SPIROX - LATERA$157
- ENTELLUS - ENTELLUS MEDICAL SHAVER SYSTEM$130
- TEZSPIRE$125
- VivAer$105
- RhinAer$105
How this compares
$10,164 in reported general payments places this provider in the 85th percentile of 193 otolaryngology providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 30 | $109,821 |
| Cefdinir | 140 | $3,256 |
| Epinephrine | 12 | $2,466 |
| Ofloxacin | 38 | $1,505 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 108 | $1,262 |
| Ipratropium Bromide | 57 | $1,261 |
| Tobramycin-DexamethasoneTobramycin/Dexamethasone | 15 | $1,147 |
| Methylprednisolone | 164 | $1,089 |
| SynthroidLevothyroxine Sodium | 20 | $1,032 |
| Fluocinolone Acetonide Oil | 17 | $970 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 115 | $690 |
| Fluticasone Propionate | 51 | $585 |
| Azelastine Hcl | 15 | $533 |
| Pilocarpine Hcl | 12 | $523 |
| Levothyroxine Sodium | 68 | $500 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieSynthroid | $14 | $1,03220 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 193 otolaryngology providers in Indiana.
Other otolaryngology in Columbus
- Anthony SandersColumbus$8K
- Joshua GreeneAnderson$955K
- Satyan SreenathIndianapolis$103K
- Stephen FreemanCarmel$33K
- Venkata KakarlapudiNew Albany$33K
- Elisa IllingIndianapolis$28K
- Colin NeumannNew Albany$26K
- Erin KevernElkhart$26K
- Aaron DubersteinLafayette$22K
- Noah ParkerCarmel$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.